Henderson Molly 4
4 · Phathom Pharmaceuticals, Inc. · Filed Apr 7, 2023
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2023-04-06$7.27/sh−3,439$25,002→ 72,576 total
Holdings
- 338.86(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 28, 2022.
- [F2]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.